Oh, I just love it when he talks likes this:
Friday January 22, 3:46 pm Eastern Time
Company Press Release
SOURCE: Paracelsian Inc.
Paracelsian Chairman and CEO Interviewed by Wall
Street Reporter
ITHACA, N.Y., Jan. 22 /PRNewswire/ -- Paracelsian Inc. (OTC Bulletin Board: PRLN - news) announced today that Bernie
Landes, Chairman, President and CEO was interviewed on January 12, 1999 by the Wall Street Reporter.
The entire interview can be heard via the Internet at either Wall Street Reporter's website (http://wallstreetreporter.com) or at
Paracelsian's website (http://www.paracelsian.com). The interview will remain available for the remainder of 1999.
Mr. Landes reviewed the Company's background and its success over the last year in refocusing its energies to develop
substantial revenue streams from its principal assets.
Mr. Landes explains in detail how the Company's new focus on its three key business segments...Quality Assurance for herbal
products including the BioFIT(TM) Certification program, Environmental Monitoring utilizing the company's Patented screen
for Dioxin, and Drug Development taking advantage of the company's extensive library of Traditional Chinese Medicines.
''I believe that this interview signifies a heightened level of interest in Paracelsian and its potential for significant growth and
profits in the near future,'' said Mr. Landes. ''I think all interested parties will be pleased to hear just how far we've come and
how bright our prospects are for the future,'' he added.
Paracelsian is a unique biotechnology company whose business centers on the development and application of functional
bioassays. These assays are used for Quality Assurance of herbs, botanicals and other dietary supplements, in the development
of dietary supplements, OTC and pharmaceutical products, and in monitoring environmental toxins and identifying carcinogens.
Notice: This news release may contain forward-looking statements.
Investors are cautioned that such forward-looking statements involve risks and uncertainties, including but not limited to, the
results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and
other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and
other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.
No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such
statements.
SOURCE: Paracelsian Inc.
More Quotes and News:
Paracelsian Inc (OTC BB:PRLN - news)
Related News Categories: banking, biotech, medical/pharmaceutical
|
